Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Lung Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Solid Tumor 4 Rectal Neoplasms 4 Neoplasms 3 Lymphoma 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Thromboembolism 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma, Testicular 1 Teratoma 1 Spinal Cord Neoplasms 1 Seminoma 1

Interventions

Fluorodeoxyglucose F18 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cytoreductive Surgery × Fluorodeoxyglucose F18 × Clear all

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡